Fig. 4From: Monitoring the efficacy of tumor necrosis factor alpha antagonists in the treatment of Ankylosing spondylarthritis: a pilot study based on MR relaxometry techniqueChangs in T1 mapping and ASDAS in the treatment group. The values of T1-mapping and ASDAS-CRP in the treatment group decreased synchronously pre-treatment, 3 weeks, 6 weeks and 12 weeks after treatmentBack to article page